Literature DB >> 16178138

Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods.

Graham Dunn1, Mohammad Maracy, Barbara Tomenson.   

Abstract

Perfectly implemented randomized clinical trials, particularly of complex interventions, are extremely rare. Almost always they are characterized by imperfect adherence to the randomly allocated treatment and variable amounts of missing outcome data. Here we start by describing a wide variety of examples and then introduce instrumental variable methods for the analysis of such trials. We concentrate mainly on situations in which compliance is all or nothing (either the patient receives the allocated treatment or they do not--in the latter case they may receive no treatment or a treatment other than the one allocated). The main purpose of the review is to illustrate the use of latent class (finite mixture) models, using maximum likelihood, for complier-average causal effect estimation under varying assumptions concerning the mechanism of the missing outcome data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178138     DOI: 10.1191/0962280205sm403oa

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  80 in total

1.  Is there another way to take account of noncompliance in randomized controlled trials?

Authors:  Catherine E Hewitt; David J Torgerson; Jeremy N V Miles
Journal:  CMAJ       Date:  2006-08-15       Impact factor: 8.262

2.  Pragmatic trials of complex psychosocial interventions: methodological challenges.

Authors:  G Dunn
Journal:  Epidemiol Psychiatr Sci       Date:  2013-03-05       Impact factor: 6.892

3.  The statistical pitfalls of the partially randomized preference design in non-blinded trials of psychological interventions.

Authors:  Isla Gemmell; Graham Dunn
Journal:  Int J Methods Psychiatr Res       Date:  2011-03       Impact factor: 4.035

4.  Estimating the causal effect of milk powder supplementation on bone mineral density: a randomized controlled trial with both non-compliance and loss to follow-up.

Authors:  Y Chen; Q Zhang; Y Wang; Y Xiao; R Fu; H Bao; M Liu
Journal:  Eur J Clin Nutr       Date:  2015-01-28       Impact factor: 4.016

Review 5.  How the EMERGE guideline on medication adherence can improve the quality of clinical trials.

Authors:  Lina Eliasson; Sarah Clifford; Amy Mulick; Christina Jackson; Bernard Vrijens
Journal:  Br J Clin Pharmacol       Date:  2020-02-28       Impact factor: 4.335

6.  Plaster cast versus functional bracing for Achilles tendon rupture: the UKSTAR RCT.

Authors:  Matthew L Costa; Juul Achten; Susan Wagland; Ioana R Marian; Mandy Maredza; Michael Maia Schlüssel; Anna S Liew; Nick R Parsons; Susan J Dutton; Rebecca S Kearney; Sarah E Lamb; Benjamin Ollivere; Stavros Petrou
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

7.  Physical activity as a treatment for depression: the TREAD randomised trial protocol.

Authors:  Helen Baxter; Rachel Winder; Melanie Chalder; Christine Wright; Sofie Sherlock; Anne Haase; Nicola J Wiles; Alan A Montgomery; Adrian H Taylor; Ken R Fox; Debbie A Lawlor; Tim J Peters; Deborah J Sharp; John Campbell; Glyn Lewis
Journal:  Trials       Date:  2010-11-12       Impact factor: 2.279

8.  CRIMSON [CRisis plan IMpact: Subjective and Objective coercion and eNgagement] protocol: a randomised controlled trial of joint crisis plans to reduce compulsory treatment of people with psychosis.

Authors:  Graham Thornicroft; Simone Farrelly; Max Birchwood; Max Marshall; George Szmukler; Waquas Waheed; Sarah Byford; Graham Dunn; Claire Henderson; Helen Lester; Morven Leese; Diana Rose; Kim Sutherby
Journal:  Trials       Date:  2010-11-05       Impact factor: 2.279

Review 9.  Statistical Considerations of Food Allergy Prevention Studies.

Authors:  Henry T Bahnson; George du Toit; Gideon Lack
Journal:  J Allergy Clin Immunol Pract       Date:  2017 Mar - Apr

10.  Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.

Authors:  Shôn W Lewis; Thomas R E Barnes; Linda Davies; Robin M Murray; Graham Dunn; Karen P Hayhurst; Alison Markwick; Helen Lloyd; Peter B Jones
Journal:  Schizophr Bull       Date:  2006-03-15       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.